Pomalidomide-Containing Regimens (PCR) for the Treatment of Relapsed and Refractory Multiple Myeloma

被引：0
|
作者：
Jimenez-Zepeda, Victor H. [1 ]
Venner, Christopher P. [2 ]
Belch, Andrew [3 ]
Sandhu, Irwindeep [4 ]
Nikitina, Tatiana [2 ]
Hewitt, Joanne D. [5 ]
Duggan, Peter [6 ]
Neri, Paola [7 ]
Rashid-Kolvear, Fariborz [8 ]
Bahlis, Nizar J. [7 ]
机构：
[1] Univ Calgary, Div Hematol, Calgary, AB, Canada
[2] Univ Alberta, Cross Canc Inst, Edmonton, AB, Canada
[3] Cross Canc Inst, Edmonton, AB T6G 1Z2, Canada
[4] Univ Alberta, Dept Med, Div Hematol, Edmonton, AB, Canada
[5] Cross Canc Inst, Nursing, Edmonton, AB T6G 1Z2, Canada
[6] Tom Baker Canc Clin, Dept Med Oncol & Hematol, Calgary, AB, Canada
[7] Univ Calgary, Southern Alberta Canc Res Inst, Calgary, AB, Canada
[8] Calgary Lab Serv, Calgary, AB, Canada
来源：
BLOOD | 2015年 / 126卷 / 23期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [21] Pomalidomide: a novel drug to treat relapsed and refractory multiple myeloma
    Terpos, Evangelos
    Kanellias, Nikolaos
    Christoulas, Dimitrios
    Kastritis, Efstathios
    Dimopoulos, Meletios A.
    ONCOTARGETS AND THERAPY, 2013, 6 : 531 - 538
  • [22] Elotuzumab in Combination with Pomalidomide and Corticosteroids for Relapsed or Refractory Multiple Myeloma
    Sidiqi, Hasib
    McGregor, Scott
    Baker, Ross
    Carnley, Ben
    Radeski, Dejan
    Barraclough, Allison
    Augustson, Bradley
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 (01): : E83 - E84
  • [23] A Meta-Analysis of the Efficacy of Pomalidomide-Based Regimens for the Treatment of Relapsed/Refractory Multiple Myeloma After Lenalidomide Exposure
    Davies, Faith E.
    Leleu, Xavier
    Vogel, Prisca
    Dhanasiri, Sujith
    Le Nouveau, Pauline
    Weisel, Katja
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 (11): : 829 - +
  • [24] Pomalidomide for the treatment of relapsed-refractory multiple myeloma: a review of biological and clinical data
    Offidani, Massimo
    Corvatta, Laura
    Caraffa, Patrizia
    Leoni, Pietro
    Pautasso, Chiara
    Larocca, Alessandra
    Palumbo, Antonio
    EXPERT REVIEW OF ANTICANCER THERAPY, 2014, 14 (05) : 499 - 510
  • [25] Tolerability and efficacy of bortezomib containing regimens for the treatment of elderly patients affected by refractory/relapsed multiple myeloma
    Gentile, M.
    Mazzone, C.
    Iorio, C.
    Lucia, E.
    Vigna, E.
    Bisconte, M. G.
    Gentile, C.
    Morabito, F.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 150 - 151
  • [26] Treatment pattern among patients with relapsed/refractory multiple myeloma (RRMM) who had received pomalidomide-based regimens in Taiwan
    Jerry Teng, Chieh-Lin
    Yeh, Su-Peng
    Chen, Tsai-Yun
    Hung, Yu-Chin
    Lin, Yun-Chu
    Li, Sin Syue
    Wang, Ming-Chung
    Huang, Shang-Yi
    HEMATOLOGY, 2024, 29 (01)
  • [27] Real world experience with "generic" pomalidomide in relapsed refractory multiple myeloma
    Jandial, Aditya
    Mishra, Kundan
    Lad, Deepesh
    Prakash, Gaurav
    Khadwal, Alka
    Malhotra, Pankaj
    LEUKEMIA & LYMPHOMA, 2019, 60 (04) : 1102 - 1104
  • [28] Cost effectiveness of pomalidomide in patients with relapsed and refractory multiple myeloma in Sweden
    Borg, Sixten
    Nahi, Hareth
    Hansson, Markus
    Lee, Dawn
    Elvidge, Jamie
    Persson, Ulf
    ACTA ONCOLOGICA, 2016, 55 (05) : 554 - 560
  • [29] Pembrolizumab in Combination with Pomalidomide and Dexamethasone for Relapsed/Refractory Multiple Myeloma (RRMM)
    Badros, Ashraf Z.
    Hyjek, Elizabeth
    Ma, Ning
    Lesokhin, Alexander M.
    Rapoport, Aaron P.
    Kocoglu, Mehmet H.
    Lederer, Emily
    Philip, Sunita
    Lesho, Patricia
    Johnson, Ashlee
    Dell, Cameron
    Goloubeva, Olga
    Singh, Zeba
    BLOOD, 2016, 128 (22)
  • [30] Clapd (Clarithromycin, Pomalidomide, Dexamethasone) Therapy In Relapsed Or Refractory Multiple Myeloma
    Mark, Tomer M.
    Boyer, Angelique
    Rossi, Adriana C.
    Kwon, Dennis
    Pearse, Roger N.
    Zafar, Faiza
    Pekle, Karen
    Tegnestam, Linda
    Jayabalan, David
    Ely, Scott A.
    Coleman, Morton
    Chen-Kiang, Selina
    Niesvizky, Ruben
    BLOOD, 2013, 122 (21)
12345